Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection

Journal of Virology

Volumn 82, Issue 4, 2008, Pages 1739-1747

  Rechsteiner, Markus P ^a   Berger, Christoph ^a   Zauner, Ludwig ^a   Sigrist, Jürg A ^a   Weber, Matthias ^a   Longnecker, Richard ^b   Bernasconi, Michele ^a   Nadal, David ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 2A; LATENT MEMBRANE PROTEIN 2B; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AKATA CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; BURKITT LYMPHOMA; CALCIUM MOBILIZATION; CELL SURVIVAL; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE OVEREXPRESSION; GENE SWITCHING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INFECTION SENSITIVITY; LYMPHOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VIRUS LATENCY;

CALCIUM; CELL LINE, TUMOR; HERPESVIRUS 4, HUMAN; HUMANS; VIRAL MATRIX PROTEINS; VIRUS ACTIVATION; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

EID: 38849162203     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01723-07     Document Type: Article

References (39)

1. Babcock, G. J., D. Hochberg, and A. D. Thorley-Lawson. 2000. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13:497-506.
2. Babcock, G. J., and D. A. Thorley-Lawson. 2000. Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc. Natl. Acad. Sci. USA 97:12250-12255.
3. Bernasconi, M., C. Berger, J. A. Sigrist, A. Bonanomi, J. Sobek, F. K. Niggli, and D. Nadal. 2006. Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray. Virol. J. 3:43.
4. Bryant, H., and P. J. Farrell. 2002. Signal transduction and transcription factor modification during reactivation of Epstein-Barr virus from latency. J. Virol. 76:10290-10298.
5. Fruehling, S., S. K. Lee, R. Herrold, B. Freeh, G. Laux, E. Kremmer, F. A. Grasser, and R. Longnecker. 1996. Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. J. Virol. 70:6216-6226.
6. Fruehling, S., and R. Longnecker. 1997. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235:241-251.
7. Fukuda, M., and R. Longnecker. 2005. Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation. J. Virol. 79:8655-8660.
8. Gottschalk, S., C. M. Rooney, and H. E. Heslop. 2005. Post-transplant lymphoproliferative disorders. Arinu. Rev. Med. 56:29-44.
9. Indra, A. K., X. Warot, J. Brocard, J. M. Bornert, J. H. Xiao, P. Chambon, and D. Metzger. 1999. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res. 27:4324-4327.
10. Kim, P. S., and P. Arvan. 1998. Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocr. Rev. 19:173-202.
11. Kluiver, J., K. Kok, I. Pfeil, D. de Jong, T. Blokzijl, G. Harms, P. van der Vlies, A. Diepstra, C. Atayar, S. Poppema, R. Kuppers, and A. van den Berg. 2007. Global correlation of genome and transcriptome changes in classical Hodgkin lymphoma. Hematol. Oncol. 25:21-29.
12. Konishi, K., S. Maruo, H. Kato, and K. Takada. 2001. Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation. J. Gen. Virol. 82:1451-1456.
13. Küppers, R., I. Schwering, A. Brauninger, K. Rajewsky, and M. L. Hansmann. 2002. Biology of Hodgkin's lymphoma. Ann. Oncol. 13(Suppl. 1):11-18.
14. Ladell, K., M. Dorner, L. Zauner, C. Berger, F. Zucol, M. Bernasconi, F. K. Niggli, R. F. Speck, and D. Nadal. 2007. Immune activation suppresses initiation of lytic Epstein-Barr virus infection. Cell. Microbiol. 9:2055-2069.
15. Longnecker, R., B. Druker, T. M. Roberts, and E. Kieff. 1991. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J. Virol. 65:3681-3692.
16. Longnecker, R., and E. Kieff. 1990. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J. Virol. 64:2319-2326.
17. Lynch, D. T., J. S. Zimmerman, and D. T. Rowe. 2002. Epstein-Barr virus latent membrane protein 2B (LMP2B) co-localizes with LMP2A in perinuclear regions in transiently transfected cells. J. Gen. Virol. 83:1025-1035.
18. Matskova, L., I. Ernberg, T. Pawson, and G. Winberg. 2001. C-terminal domain of the Epstein-Barr virus LMP2A membrane protein contains a clustering signal. J. Virol. 75:10941-10949.
19. Meusser, B., C. Hirsch, E. Jarosch, and T. Sommer. 2005. ERAD: the long road to destruction. Nat. Cell Biol. 7:766-772.
20. Miller, C. L., A. L. Burkhardt, J. H. Lee, B. Stealey, R. Longnecker, J. B. Bolen, and E. Kieff. 1995. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2:155-166.
21. Miller, C. L., J. H. Lee, E. Kieff, and R. Longnecker. 1994. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc. Natl. Acad. Sci. USA 91:772-776.
22. Miller, C. L., R. Longnecker, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J. Virol. 67:3087-3094.
23. Miller, G., and M. Lipman. 1973. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA 70:190-194.
24. Murray, P. G., and L. S. Young. 2002. The Role of the Epstein-Barr virus in human disease. Front. Biosci. 7:d519-d540.
25. Portis, T., and R. Longnecker. 2004. Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation. Virology 318:524-533.
26. Portis, T., and R. Longnecker. 2004. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Oncogene 23:8619-8628.
27. Rechsteiner, M. P., C. Berger, M. Weber, J. A. Sigrist, D. Nadal, and M. Bernasconi. 2007. Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells. J. Gen. Virol. 88:1454-1459.
28. Rickinson, A., and E. Kieff. 2001. Epstein-Barr virus, p. 2575-2627. In Knipe, D. M., P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA.
29. Rovedo, M., and R. Longnecker. 2007. Epstein-Barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity. J. Virol. 81:84-94.
30. Rowe, D. T. 1999. Epstein-Barr virus immortalization and latency. Front. Biosci. 4:D346-D371.
31. Sample, J., D. Liebowitz, and E. Kieff. 1989. Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J. Virol. 63:933-937.
32. Schaadt, E., B. Baier, J. Mautner, G. W. Bornkamm, and B. Adler. 2005. Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation. J. Gen. Virol. 86:551-559.
33. Schaefer, B. C., T. C. Mitchell, J. W. Kappler, and P. Marrack. 2001. A novel family of retroviral vectors for the rapid production of complex stable cell lines. Anal. Biochem. 297:86-93.
34. Sugden, B., and W. Mark. 1977. Clonal transformation of adult human leukocytes by Epstein-Barr virus. J. Virol. 23:503-508.
35. Swart, R., I. K. Ruf, J. Sample, and R. Longnecker. 2000. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-kinase/Akt pathway. J. Virol. 74:10838-10845.
36. Takada, K. 1984. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer 33:27-32.
37. Tomaszewski-Flick, M. J., and D. T. Rowe. 2007. Minimal protein domain requirements for the intracellular localization and self-aggregation of Epstein-Barr virus latent membrane protein 2. Virus Genes 35:225-234.
38. Young, L. S., and P. G. Murray. 2003. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22:5108-5121.
39. Yuan, J., E. Cahir-McFarland, B. Zhao, and E. Kieff. 2006. Virus and cell RNAs expressed during Epstein-Barr virus replication. J. Virol. 80:2548-2565.